The FDA's acceptance of the NDA is a positive step for XOMA,...
The FDA's acceptance of the NDA is a positive step for XOMA, triggering a milestone payment and bringing the drug closer to potential approval and commercialization. This could lead to future milestone and royalty payments for XOMA, depending on arimoclomol's commercial success.
Press Release: FDA Acceptance of Zevra's Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRx
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
4491Followers
0Following
9833Visitors
Follow